HEADER TRANSCRIPTION 03-NOV-15 5EK9
TITLE CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD2 IN COMPLEX
TITLE 2 WITH A TETRAHYDROQUINOLINE INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 344-455;
COMPND 5 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BRD2, KIAA9001, RING3;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS CHROMATIN AND TRANSCRIPTION REGULATOR, ACETYLATION, STRUCTURAL
KEYWDS 2 GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR C.TALLANT,P.J.SLAVISH,P.SIEJKA,N.BHARATHAM,W.R.SHADRICK,S.CHAI,
AUTHOR 2 B.M.YOUNG,V.A.BOYD,C.HEROVEN,S.PICAUD,O.FEDOROV,T.CHEN,R.E.LEE,
AUTHOR 3 R.K.GUY,A.A.SHELAT,F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS,C.BOUNTRA,
AUTHOR 4 S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM (SGC)
REVDAT 5 08-MAY-24 5EK9 1 REMARK
REVDAT 4 17-JAN-18 5EK9 1 JRNL
REVDAT 3 13-DEC-17 5EK9 1 JRNL
REVDAT 2 29-NOV-17 5EK9 1 JRNL
REVDAT 1 16-NOV-16 5EK9 0
JRNL AUTH W.R.SHADRICK,P.J.SLAVISH,S.C.CHAI,B.WADDELL,M.CONNELLY,
JRNL AUTH 2 J.A.LOW,C.TALLANT,B.M.YOUNG,N.BHARATHAM,S.KNAPP,V.A.BOYD,
JRNL AUTH 3 M.MORFOUACE,M.F.ROUSSEL,T.CHEN,R.E.LEE,R.KIPLIN GUY,
JRNL AUTH 4 A.A.SHELAT,P.M.POTTER
JRNL TITL EXPLOITING A WATER NETWORK TO ACHIEVE ENTHALPY-DRIVEN,
JRNL TITL 2 BROMODOMAIN-SELECTIVE BET INHIBITORS.
JRNL REF BIOORG. MED. CHEM. V. 26 25 2018
JRNL REFN ESSN 1464-3391
JRNL PMID 29170024
JRNL DOI 10.1016/J.BMC.2017.10.042
REMARK 2
REMARK 2 RESOLUTION. 2.08 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0073
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.08
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.21
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 3 NUMBER OF REFLECTIONS : 16963
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.184
REMARK 3 R VALUE (WORKING SET) : 0.182
REMARK 3 FREE R VALUE : 0.223
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 914
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.09
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.14
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1130
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.56
REMARK 3 BIN R VALUE (WORKING SET) : 0.2540
REMARK 3 BIN FREE R VALUE SET COUNT : 64
REMARK 3 BIN FREE R VALUE : 0.3030
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1776
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 52
REMARK 3 SOLVENT ATOMS : 101
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.35
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.64000
REMARK 3 B22 (A**2) : -0.32000
REMARK 3 B33 (A**2) : -0.32000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.177
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.011
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1882 ; 0.012 ; 0.019
REMARK 3 BOND LENGTHS OTHERS (A): 1776 ; 0.001 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2540 ; 1.483 ; 1.935
REMARK 3 BOND ANGLES OTHERS (DEGREES): 4088 ; 0.827 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 212 ; 5.222 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 94 ;32.458 ;23.404
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 326 ;15.171 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;19.816 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 254 ; 0.091 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2228 ; 0.007 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 456 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 854 ; 1.656 ; 2.276
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 853 ; 1.647 ; 2.273
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1068 ; 2.620 ; 3.403
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1069 ; 2.623 ; 3.403
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1028 ; 2.574 ; 2.719
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1029 ; 2.573 ; 2.719
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1473 ; 4.210 ; 3.915
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2241 ; 5.725 ;18.925
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2242 ; 5.727 ;18.930
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 348 B 454
REMARK 3 ORIGIN FOR THE GROUP (A): 14.2704 17.3137 58.1328
REMARK 3 T TENSOR
REMARK 3 T11: 0.0685 T22: 0.0184
REMARK 3 T33: 0.0187 T12: 0.0123
REMARK 3 T13: -0.0062 T23: 0.0036
REMARK 3 L TENSOR
REMARK 3 L11: 1.0546 L22: 0.2778
REMARK 3 L33: 1.1481 L12: 0.0162
REMARK 3 L13: 0.2138 L23: 0.4860
REMARK 3 S TENSOR
REMARK 3 S11: 0.0079 S12: -0.0506 S13: 0.0523
REMARK 3 S21: -0.0153 S22: -0.0340 S23: -0.0120
REMARK 3 S31: -0.1218 S32: -0.0451 S33: 0.0261
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 348 B 454
REMARK 3 ORIGIN FOR THE GROUP (A): 20.5502 -0.8872 48.1762
REMARK 3 T TENSOR
REMARK 3 T11: 0.0622 T22: 0.0086
REMARK 3 T33: 0.0112 T12: 0.0064
REMARK 3 T13: 0.0188 T23: 0.0043
REMARK 3 L TENSOR
REMARK 3 L11: 0.8548 L22: 0.5295
REMARK 3 L33: 0.5603 L12: -0.2882
REMARK 3 L13: -0.4124 L23: -0.1719
REMARK 3 S TENSOR
REMARK 3 S11: -0.0244 S12: -0.0159 S13: -0.0282
REMARK 3 S21: -0.0398 S22: 0.0103 S23: 0.0333
REMARK 3 S31: 0.0629 S32: -0.0006 S33: 0.0141
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 5EK9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-NOV-15.
REMARK 100 THE DEPOSITION ID IS D_1000215065.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-NOV-14
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I02
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9794
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17910
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.080
REMARK 200 RESOLUTION RANGE LOW (A) : 29.210
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 200 DATA REDUNDANCY : 12.60
REMARK 200 R MERGE (I) : 0.15900
REMARK 200 R SYM (I) : 0.06700
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14
REMARK 200 COMPLETENESS FOR SHELL (%) : 92.8
REMARK 200 DATA REDUNDANCY IN SHELL : 11.60
REMARK 200 R MERGE FOR SHELL (I) : 0.80000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: ROD
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 55.35
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG6000, 0.1M CITRATE PH5, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -X,Y,-Z+1/2
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.60750
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.60750
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.85200
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 34.87450
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.85200
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 34.87450
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.60750
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.85200
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 34.87450
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.60750
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.85200
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 34.87450
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH B 641 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A 342
REMARK 465 MET A 343
REMARK 465 GLY A 344
REMARK 465 LYS A 345
REMARK 465 LEU A 346
REMARK 465 SER A 347
REMARK 465 ASP A 455
REMARK 465 SER B 342
REMARK 465 MET B 343
REMARK 465 GLY B 344
REMARK 465 LYS B 345
REMARK 465 LEU B 346
REMARK 465 SER B 347
REMARK 465 ASP B 455
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5P4 A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5P4 B 501
DBREF 5EK9 A 344 455 UNP P25440 BRD2_HUMAN 344 455
DBREF 5EK9 B 344 455 UNP P25440 BRD2_HUMAN 344 455
SEQADV 5EK9 SER A 342 UNP P25440 EXPRESSION TAG
SEQADV 5EK9 MET A 343 UNP P25440 EXPRESSION TAG
SEQADV 5EK9 SER B 342 UNP P25440 EXPRESSION TAG
SEQADV 5EK9 MET B 343 UNP P25440 EXPRESSION TAG
SEQRES 1 A 114 SER MET GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN
SEQRES 2 A 114 GLY ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA
SEQRES 3 A 114 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA
SEQRES 4 A 114 LEU GLY LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO
SEQRES 5 A 114 MET ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG
SEQRES 6 A 114 ASP TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG
SEQRES 7 A 114 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP
SEQRES 8 A 114 HIS ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL
SEQRES 9 A 114 PHE GLU PHE ARG TYR ALA LYS MET PRO ASP
SEQRES 1 B 114 SER MET GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN
SEQRES 2 B 114 GLY ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA
SEQRES 3 B 114 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA
SEQRES 4 B 114 LEU GLY LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO
SEQRES 5 B 114 MET ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG
SEQRES 6 B 114 ASP TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG
SEQRES 7 B 114 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP
SEQRES 8 B 114 HIS ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL
SEQRES 9 B 114 PHE GLU PHE ARG TYR ALA LYS MET PRO ASP
HET 5P4 A 501 26
HET 5P4 B 501 26
HETNAM 5P4 PROPAN-2-YL ~{N}-[(2~{S},4~{R})-1-ETHANOYL-6-(FURAN-2-
HETNAM 2 5P4 YL)-2-METHYL-3,4-DIHYDRO-2~{H}-QUINOLIN-4-YL]CARBAMATE
FORMUL 3 5P4 2(C20 H24 N2 O4)
FORMUL 5 HOH *101(H2 O)
HELIX 1 AA1 GLU A 348 SER A 362 1 15
HELIX 2 AA2 HIS A 365 TRP A 370 1 6
HELIX 3 AA3 PRO A 371 TYR A 373 5 3
HELIX 4 AA4 ASP A 377 GLY A 382 1 6
HELIX 5 AA5 ASP A 385 ILE A 390 1 6
HELIX 6 AA6 ASP A 395 ASN A 405 1 11
HELIX 7 AA7 ASP A 410 ASN A 429 1 20
HELIX 8 AA8 HIS A 433 MET A 453 1 21
HELIX 9 AA9 GLN B 349 SER B 362 1 14
HELIX 10 AB1 HIS B 365 TRP B 370 1 6
HELIX 11 AB2 PRO B 371 TYR B 373 5 3
HELIX 12 AB3 ASP B 385 ILE B 390 1 6
HELIX 13 AB4 ASP B 395 ASN B 405 1 11
HELIX 14 AB5 ASP B 410 ASN B 429 1 20
HELIX 15 AB6 HIS B 433 LYS B 452 1 20
SITE 1 AC1 9 TRP A 370 PRO A 371 PHE A 372 LEU A 381
SITE 2 AC1 9 LEU A 383 CYS A 425 ASN A 429 HIS A 433
SITE 3 AC1 9 HOH A 617
SITE 1 AC2 7 TRP B 370 PRO B 371 LEU B 381 ASN B 429
SITE 2 AC2 7 ASP B 434 HOH B 602 HOH B 647
CRYST1 59.704 69.749 141.215 90.00 90.00 90.00 C 2 2 21 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016749 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014337 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007081 0.00000